Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C32H40N8O2S |
Molecular Weight | 600.777 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1N=CC2=C1NC3=CC=CC=C3N(C2)C(=O)C4=CC(C)=C(CNC(=O)N5CCC[C@H]5C(=S)N6CCCN(C)CC6)C=C4
InChI
InChIKey=KSNHHKZYKYNBEI-NDEPHWFRSA-N
InChI=1S/C32H40N8O2S/c1-22-18-23(30(41)40-21-25-20-34-37(3)29(25)35-26-8-4-5-9-27(26)40)11-12-24(22)19-33-32(42)39-15-6-10-28(39)31(43)38-14-7-13-36(2)16-17-38/h4-5,8-9,11-12,18,20,28,35H,6-7,10,13-17,19,21H2,1-3H3,(H,33,42)/t28-/m0/s1
Molecular Formula | C32H40N8O2S |
Molecular Weight | 600.777 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/15357997
Sources: https://www.ncbi.nlm.nih.gov/pubmed/15357997
TC OT 39 was developed as potent non-peptide oxytocin receptor partial agonist and V2 vasopressin receptor agonist. Also was a V1a vasopressin receptor antagonist.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2049 Sources: https://www.ncbi.nlm.nih.gov/pubmed/15357997 |
33.0 nM [EC50] | ||
Target ID: CHEMBL1790 Sources: https://www.ncbi.nlm.nih.gov/pubmed/20104850 |
850.0 nM [EC50] | ||
Target ID: CHEMBL1889 Sources: https://www.ncbi.nlm.nih.gov/pubmed/20104850 |
330.0 nM [Ki] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 17:00:31 GMT 2023
by
admin
on
Sat Dec 16 17:00:31 GMT 2023
|
Record UNII |
RMV6SD8REW
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
135413563
Created by
admin on Sat Dec 16 17:00:31 GMT 2023 , Edited by admin on Sat Dec 16 17:00:31 GMT 2023
|
PRIMARY | |||
|
479232-57-0
Created by
admin on Sat Dec 16 17:00:31 GMT 2023 , Edited by admin on Sat Dec 16 17:00:31 GMT 2023
|
PRIMARY | |||
|
RMV6SD8REW
Created by
admin on Sat Dec 16 17:00:31 GMT 2023 , Edited by admin on Sat Dec 16 17:00:31 GMT 2023
|
PRIMARY | |||
|
DTXSID301031871
Created by
admin on Sat Dec 16 17:00:31 GMT 2023 , Edited by admin on Sat Dec 16 17:00:31 GMT 2023
|
PRIMARY | |||
|
TC OT 39
Created by
admin on Sat Dec 16 17:00:31 GMT 2023 , Edited by admin on Sat Dec 16 17:00:31 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
ANTAGONIST
|
||
|
TARGET->PARTIAL AGONIST |
|
||
|
TARGET->PARTIAL AGONIST |
|